GeoVax Appoints Mark J. Newman, Ph.D. Chief Scientific Officer
ATLANTA, GA, Aug. 26, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, announces today the appointment of Mark J. …